Spontaneous Bacterial Peritonitis as a Precipitating Factor of Hepatic Encephalopathy and Its Outcomes During Hospital Admission
DOI:
https://doi.org/10.70749/ijbr.v3i3.654Keywords:
Hepatic Encephalopathy, Spontaneous Bacterial Peritonitis, OutcomeAbstract
Introduction: Hepatic encephalopathy (HE) is a well-recognized clinical complication of liver cirrhosis and the presence and prompt identification of well-defined precipitating factors are extremely important in the diagnosis and treatment of this fatal condition. HE develops in 50% to 70% of patients with cirrhosis, and its occurrence is a poor prognostic indicator. Objectives: To determine the outcome (in terms of complete reversal of HE) of hepatic encephalopathy patients with Spontaneous bacterial peritonitis (SBP). Materials & Methods: 126 patients of hepatic encephalopathy and ascites with spontaneous bacterial peritonitis of age 20-60 years of either gender were enrolled. Patients with fulminant hepatic failure, non-cirrhotic portal hypertension, uremic, anoxic, cerebral and metabolic encephalopathy were excluded. All patients underwent standard management during their hospital stay. All the patients were assessed with these criteria and on daily basis for noting an improvement/deterioration in HE grades. Improvement of HE was defined as complete reversal of clinical symptoms on the basis of the West Haven criteria Patients with HE of ≥ grade 1 on discharge was considered as no improvement. Results: The study's age range was 20 to 60 years old, with a mean age of 42.15 ± 9.87 years. Majority of patients i.e. 62.70%, were between 41-60 years of age. Of these 126 patients, 65 (51.59%) were males and 61 (58.41%) were females with male to female ratio of 1.1:1. Mean duration of cirrhosis was 3.51 ± 1.16 years. Improved outcome (in terms of complete reversal of HE) of hepatic encephalopathy patients with Spontaneous bacterial peritonitis (SBP) was found in 111 (88.10%) patients. Conclusion: According to the study's findings, successful clinical outcomes can result from the early detection of hepatic encephalopathy's precipitant variables and subsequent care.
Downloads
References
Poudyal NS, Chaudhary S, Sudhamshu KC, Paudel BN, Basnet BK, Mandal A, et al. Precipitating factors and treatment outcomes of hepatic encephalopathy in liver cirrhosis. Cureus. 2019; 11(4): 1-9. https://doi.org/10.7759/cureus.4363
Singeap AM, Cuciureanu T, Zenovia S, Girleanu I, Huiban L, Muzica CM, et al. Spectrum of Precipitating factors of Hepatic Encephalopathy in Patients with Liver Cirrhosis. Med Surg J. 2021; 125(4):492-501. https://doi.org/10.22551/msj.2021.04.04
Kamal SM, Abdelhakam SM, Massoud YM, Abd El Hafeez KA, Kamal HA. Clinical profile of patients with ascitic fluid infection at ain shams university hospitals. Egypt J Hosp Med. 2018; 72 (9): 5241-50. https://doi.org/10.21608/ejhm.2018.10862
Hadjihambi A, Arias N, Sheikh M, Jalan R. Hepatic encephalopathy: a critical current review. Hepatology int. 2018; 12(1): 135-47 https://doi.org/10.1007/s12072-017-9812-3
Ullah T, Iqbal M, Ali S, Ullah I. Precipitating Factors of Hepatic Encephalopathy in Patients With Liver Cirrhosis. Med Forum. 2020; 31(4). 54-57.
Mumtaz K, Ahmed US, Abid S, Baig N, Hamid S, Jafri W. Precipitating factors and the outcome of hepatic encephalopathy in liver cirrhosis. J Coll Physician & Surgeons Pak. 2010; 20(8):514-18.
Moreau R, Elkrief L, Bureau C. Effects of long-term norfloxacin therapy in patients with advanced cirrhosis. Gastroenterology. 2018 Dec; 155(6):1816–1827. https://doi.org/10.1053/j.gastro.2018.08.026
Tsung PC, Ryu SH, Cha IH. Predictive factors that influence the survival rates in liver cirrhosis patients with spontaneous bacterial peritonitis. Clin Mol Hepatol. 2013; 19(2):131–139. https://doi.org/10.3350/cmh.2013.19.2.131
Bal CK, Daman R, Bhatia V. Predictors of fifty days in-hospital mortality in decompensated cirrhosis patients with spontaneous bacterial peritonitis. World J Hepatol. 2016; 8(12):566–572. https://doi.org/10.4254/wjh.v8.i12.566
Cheong HS, Kang CI, Lee JA. Clinical significance and outcome of nosocomial acquisition of spontaneous bacterial peritonitis in patients with liver cirrhosis. Clin Infect Dis. 2009; 48(9):1230–1236. https://doi.org/10.1086/597585
D’Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2006; 44(1):217–231. https://doi.org/10.1016/j.jhep.2005.10.013
Marciano S, Dirchwolf M, Bermudez CS. Spontaneous bacteremia and spontaneous bacterial peritonitis share similar prognosis in patients with cirrhosis: a cohort study. Hepatol Int. 2018; 12(2):181–190. https://doi.org/10.1007/s12072-017-9837-7
Ginés P, Rimola A, Planas R, et al. Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial. Hepatology. 1990; 12(4 Pt 1):716–724. https://doi.org/10.1002/hep.1840120416
Titó L, Rimola A, Ginès P, Llach J, Arroyo V, Rodés J. Recurrence of spontaneous bacterial peritonitis in cirrhosis: frequency and predictive factors. Hepatology. 1988; 8(1):27– 31. https://doi.org/10.1002/hep.1840080107
Fiore M, Maraolo AE, Gentile I. Nosocomial spontaneous bacterial peritonitis antibiotic treatment in the era of multi-drug resistance pathogens: a systematic review. World J Gastroenterol. 2017; 23(25): 4654– 4660. https://doi.org/10.3748/wjg.v23.i25.4654
Fernández J, Bert F, Nicolas-Chanoine MH. The challenges of multidrug-resistance in hepatology. J Hepatol. 2016; 65(5):1043–1054. https://doi.org/10.1016/j.jhep.2016.08.006
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Indus Journal of Bioscience Research

This work is licensed under a Creative Commons Attribution 4.0 International License.
